Accessibility Menu

Ucb(FRA) UNC

Market Cap€41.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€220.40
+2.08%
+4.50Today

Ucb Financials at a Glance

Market Cap

€41.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€11.31

P/E Ratio

18.73

Dividend

€1.45

Beta (Volatility)

0.12 (Low)

Price

€220.40

Volume

69

Open

€214.90

Previous Close

€215.90

Daily Range

€214.90 - €220.40

52-Week Range

€194.40 - €285.40

Estimated Earnings Date

N/A

UNC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ucb

UCB SA engages in the research and development biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

Industry

Pharmaceuticals

Sector

Health Care

Employees

10,117

CEO

Jean-Christophe Tellier, MD

Website

www.ucb.com

UNC Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

20.57%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

5.34%

Dividend Yield

0.67%

Payout Ratio

N/A

Stock Overview

Market Cap

€41.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

190.66M

Volume

69

Avg. Volume

28.985

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Ucb Performance Analysis

Ucb annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 5,517,000,000-4.5%
20232023-12-31EUR 5,252,000,000-4.8%
20242024-12-31EUR 6,152,000,00017.1%
20252025-12-31EUR 7,741,000,00025.8%
Ucb annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 2.15-60.6%
20232023-12-31EUR 1.76-18.1%
20242024-12-31EUR 5.47211.5%
20252025-12-31EUR 8.0246.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€41.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
BIAFbioAffinity Technologies
$6.37+0.40%
NVDANvidia
$217.93-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.46-0.05%
INTCIntel
$88.68-0.01%

Questions About UNC

What is the current price of Ucb?

Ucb is trading at €220.40 per share.

What is the 52-week range for Ucb?

Over the past 52 weeks, Ucb has traded between €194.40 and €285.40.

How much debt does Ucb have?

As of the most recent reporting period, Ucb reported total debt of €2.25B.

How much cash does Ucb have on hand?

Ucb reported €2.25B in cash and cash equivalents in its most recent financial results.

What is Ucb’s dividend yield?

Ucb currently has a dividend yield of 0.67%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services